16 matches for your search in the start-up spotlight
rss
Interface Polymers' technology simplifies processing and recycling of plastics
21-Mar-2023
Evonik has invested in the British company Interface Polymers Ltd. This company’s Polarfin® additives simplify the processing of plastics such as mixtures with polyethylene or polypropylene. At the same time, its technology makes it possible to recycle such plastics, thereby solving one of the ...
3D printed tablets with better drug delivery
09-Mar-2022
Evonik Venture Capital has invested in Laxxon Medical. The Nevada, U.S.-based company has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time. Multiple ingredients can also be ...
Revivo BioSystems has developed technology that uses a model of human skin for testing
02-Dec-2021
Evonik has invested in start-up Revivo BioSystems to support the development and commercialization of a technology that uses a realistic 4D model of human skin for the testing of chemical, cosmetic and pharmaceutical compounds. The Singapore start-up’s technology provides an alternative to animal ...
Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business
04-Aug-2021
Evonik has acquired German biotech company JeNaCell. The acquisition expands Evonik’s biomaterials portfolio to provide biotechnologically derived cellulose. The nature-identical material developed by JeNaCell is used in medical technology and dermatology for the treatment of wounds and burns as ...
Biotechnology start-up reaches commercialization stage for its technology
06-Apr-2021
Evonik has made a follow-up investment in the biotechnology start-up In Ovo through its venture capital unit. The investment comes as the young company reaches the commercialization stage for its technology and is bringing its gender-testing machine for eggs to the market. Together with ...
Successful venture capital exit
23-Oct-2020
Evonik Venture Capital has sold its stake in Synoste Oy to Globus Medical. Evonik’s four-and-a-half-year partnership with the Finnish start-up was beneficial to both companies, supporting the development of Synoste’s technology for orthopedics and giving Evonik further insights into the medical ...
With this cooperation, chembid and Evonik want to simplify the processes from the production to the sale of coating products for their customers
20-Jul-2020
chembid and the Coating Additives Business Line of Evonik announce their cooperation. The platforms have set themselves the goal of making processes and decisions for chemical companies more efficient and driving forward the digitization in the chemical industry. The basis for this are ...
28-Oct-2019
Evonik Venture Capital has invested in an Israeli software start-up that helps industrial companies adopt 3D printing. Castor Technologies has developed a software that assesses a part’s printability, the best printing material, cost and lead time. The technology helps manufacturers decide if and ...
Development of custom-made specialty chemical components for the next generation of materials
01-Oct-2019
Evonik and Cubicure, a spin-off company of Vienna University of Technology, have entered into a cooperative agreement to jointly develop innovative radiation-curing resin systems. The partnership with the start-up company is managed by Creavis, the strategic innovation unit of the specialty ...
20-Sep-2019
Evonik’s venture capital arm has invested in a start-up that sustainably produces biofabricated materials that are inspired by leather, eliminating the need for animal skins. Modern Meadow’s technology produces animal-free collagen, a protein naturally found in animal hides, via a fermentation ...
